West makes minority investment in dublin-based latch medical, a developer of vaccine and biologics delivery platforms

Exton, pa. , aug. 11, 2022 /prnewswire/ -- west pharmaceutical services, inc. (nyse: wst), a global leader in innovative solutions for injectable drug administration, today announced it has made a strategic investment in latch medical, a dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a new approach to intradermal delivery. "west's investment in latch medical advances our leadership in innovation through a dedicated focus on the needs of patients," says robert segura, vice president, corporate development, west pharmaceutical services.
WST Ratings Summary
WST Quant Ranking